Last reviewed · How we verify
GLS-5700
At a glance
| Generic name | GLS-5700 |
|---|---|
| Sponsor | GeneOne Life Science, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas (PHASE2)
- GLS-5700 in Dengue Virus-Naïve Adults (PHASE1)
- GLS-5700 in Dengue Virus Seropositive Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |